We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$824M
AUM Growth
+$71.1M
Cap. Flow
+$34.5M
Cap. Flow %
4.19%
Top 10 Hldgs %
11.01%
Holding
412
New
24
Increased
206
Reduced
148
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 15.33%
2 Financials 11.1%
3 Healthcare 10.59%
4 Industrials 9.77%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPGP icon
276
IPG Photonics
IPGP
$3.84B
$1.31M 0.16%
13,302
+885
+7% +$82.5K
IMMR icon
277
Immersion
IMMR
$252M
$1.31M 0.16%
123,377
-3,406
-3% -$32.1K
ADSK icon
278
Autodesk
ADSK
$52.6B
$1.31M 0.16%
17,669
+3,702
+27% +$273K
GCI
279
DELISTED
Gannett Co., Inc
GCI
$1.29M 0.16%
133,403
-10,102
-7% -$98.9K
NVDA icon
280
NVIDIA
NVDA
$5.42T
$1.28M 0.16%
478,400
-143,080
-23% -$299K
MSFT icon
281
Microsoft
MSFT
$3.71T
$1.27M 0.15%
20,497
-7,237
-26% -$435K
AMGN icon
282
Amgen
AMGN
$222B
$1.22M 0.15%
8,320
+407
+5% +$61.3K
SYKE
283
DELISTED
SYKES Enterprises Inc
SYKE
$1.14M 0.14%
39,613
-225
-0.6% -$6.28K
GOOGL icon
284
Alphabet (Google) Class A
GOOGL
$4.33T
$1.1M 0.13%
27,880
-9,160
-25% -$366K
JPC icon
285
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$1.05M 0.13%
107,298
+5,384
+5% +$51.6K
DBI icon
286
Designer Brands
DBI
$333M
$1.04M 0.13%
45,807
+187
+0.4% +$4.24K
XONE
287
DELISTED
The ExOne Company
XONE
$1.01M 0.12%
108,718
+72,383
+199% +$827K
EBS icon
288
Emergent Biosolutions
EBS
$248M
$962K 0.12%
29,283
+1,639
+6% +$49.1K
PFE icon
289
Pfizer
PFE
$153B
$859K 0.1%
27,860
-26,053
-48% -$795K
MRK icon
290
Merck
MRK
$318B
$848K 0.1%
15,088
+568
+4% +$33.2K
CHTR icon
291
Charter Communications
CHTR
$18.2B
$846K 0.1%
+2,295
New +$618K
INCY icon
292
Incyte
INCY
$24.4B
$805K 0.1%
6,065
-7,402
-55% -$722K
META icon
293
Meta Platforms (Facebook)
META
$1.51T
$801K 0.1%
5,590
+2,001
+56% +$246K
ADAP
294
DELISTED
Adaptimmune Therapeutics
ADAP
$785K 0.1%
193,869
+120,724
+165% +$579K
DY icon
295
Dycom Industries
DY
$12.3B
$779K 0.09%
9,701
-1,874
-16% -$152K
ICLR icon
296
Icon
ICLR
$12.7B
$777K 0.09%
10,338
-560
-5% -$43.5K
LLY icon
297
Eli Lilly
LLY
$1.06T
$777K 0.09%
10,563
+4,323
+69% +$322K
STZ icon
298
Constellation Brands
STZ
$23.2B
$773K 0.09%
3,973
-1,374
-26% -$218K
MGNX icon
299
MacroGenics
MGNX
$257M
$766K 0.09%
37,487
+10,904
+41% +$274K
CRIS icon
300
Curis
CRIS
$7.83M
$763K 0.09%
+124
New +$745K

Similar funds

Vident Investment Advisory's Q4 2016 Portfolio in Review

As of Q4 2016, Vident Investment Advisory held 412 positions worth $824M, up 9.4% from $753M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Vident Investment Advisory deployed $34.5M of net new capital in Q4 2016, opening 24 new positions and adding to 206 existing holdings. Its largest new stake was Qualcomm: 22,530 shares worth $1.47M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.91M trimmed.

  • Vident Investment Advisory's largest Q4 2016 buy was Qualcomm: 22,530 shares worth $1.47M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q4 2016, an estimated $30.7M increase.
  • Vident Investment Advisory's biggest Q4 2016 reduction was Johnson & Johnson, cutting an estimated $1.91M.
  • Vident Investment Advisory fully exited Rackspace Hosting Inc in Q4 2016, selling an estimated $3.13M.
  • Vident Investment Advisory's ten largest holdings make up 11% of its $824M portfolio in Q4 2016.
  • Vident Investment Advisory opened 24 new positions and closed 33 in Q4 2016.
  • Vident Investment Advisory's portfolio value rose 9.4% quarter-over-quarter to $824M.

Based on Vident Investment Advisory's 13F filing for Q4 2016, filed 14 Feb 2017.